FlowMet-R
Device Intraprocedural Monitoring
PDI 00860001276107
General payments
$10,736
Research payments
$1,030,432
Through program year 2023, $10,736 in general payments and $1,030,432 in research payments were reported against FlowMet-R (Intraprocedural Monitoring).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $2 | 1 |
| 2023 | Research | $190,527 | 35 |
| 2022 | General | $3,194 | 12 |
| 2022 | Research | $441,827 | 46 |
| 2021 | General | $7,540 | 25 |
| 2021 | Research | $398,079 | 17 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
38 general · 98 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.